The year 2021 saw revisions to the PhRMA Code as well as new FDA guidance regarding off-label promotion. In this program, Alison Morrissey, McCarter & English, LLP and Jacqueline C. Gorbey, Endo Pharmaceuticals Inc., discuss these updates and provide guidance on how pharmaceutical companies can navigate these changes and remain compliant during the Association of Corporate Counsel’s Health, Biotech & Pharma CLE Institute.
10.19.2022